Abstract:This meta-analysis was performed to evaluate the relationships between promoter DNA methylation in tumor suppressor gene p16 and gastric carcinogenesis. The PubMed, CISCOM, CINAHL, Web of Science, Google Scholar, EBSCO, Cochrane Library and CBM databases were searched for relevant articles published before November 1st, 2013 without any language restrictions. Meta-analysis was conducted using the STATA 12.0 software. Crude odds ratios (ORs) with 95 % confidence intervals (95 % CI) were calculated. Forty-seven clinical cohort studies that met all inclusion criteria were included in this meta-analysis. A total of 2,813 gastric cancer (GC) patients were assessed. Our meta-analysis results revealed that the frequencies of p16 promoter methylation in the GC tissues were higher than those of normal and adjacent tissues (Normal: OR = 23.04, 95 % CI = 13.55–39.15, P < 0.001; Adjacent: OR = 4.42, 95 % CI = 1.66–11.76, P = 0.003; respectively). Furthermore, we observed significant associations of p16 promoter methylation with TNM stage, histologic grade, invasive grade, lymph node metastasis of GC (TNM stage: OR = 3.60, 95 % CI: 2.17–5.98, P < 0.001; Histologic grade: OR = 2.63, 95 % CI: 1.55–4.45, P < 0.001; Invasive grade: OR = 3.44, 95 % CI: 1.68–7.06, P = 0.001; Lymph node metastasis: OR = 2.68, 95 % CI: 1.66–4.32, P < 0.001; respectively). However, there were no correlations of p16 promoter methylation with the TNM stage and Helicobacter pylori (HP) infection of GC (Tumor size: OR = 0.76, 95 % CI: 0.14–4.07, P = 0.746; HP infection: OR = 1.31, 95 % CI: 0.75–2.27, P = 0.342; respectively). Our findings provide empirical evidence that p16 promoter methylation may play an important role in gastric carcinogenesis. Thus, p16 promoter methylation may be a promising potential biomarker for the early diagnosis of GC.

Diagnostic value of serum P 16 gene promoter methylation in gastric cancer : a meta-analysis

RETRACTED ARTICLE: Role of P16 Gene Promoter Methylation in Gastric Carcinogenesis: a Meta-Analysis

Correlation of p16 gene methylation with protein expression in gastric cancer and its clinical significance

Methylation of CpG Islands of P16 Associated with Progression of Primary Gastric Carcinomas

Hypermethylation of CpG island at p16 gene promoter in gastric carcinomas

Analysis of aberrant methylation of p16 gene promoter in tissue from gastric cancer patients

The Prognostic Value Of P16 Hypermethylation In Cancer: A Meta-Analysis

Promoter Hypermethylation of P16 Gene in Pre- and Post-Operative Plasma of Patients with Gastric Adenocarcinoma

Detection of p16 Hypermethylation in Gastric Carcinomas Using a Seminested Methylation-Specific PCR

Diagnostic Accuracy Of Dna Methylation In Detection Of Gastric Cancer: A Meta-Analysis

[Diagnostic Value of BRCA1 and P16 Gene Methylation in Sporadic Breast Cancer].

Potential Diagnostic and Prognostic Values of Detecting Promoter Hypermethylation in the Serum of Patients with Gastric Cancer

Study of P16 Tumor Suppressor Gene with Methylation-Specific PCR

Detection of Serum RASSF1A Gene Promoter Methylation in Patients with Gastric Cancer

Diagnostic Value of P16 Methylation for Malignant Pleural Effusions: A Meta-analysis.

Correlation Between Suppressor Genes Promoter Hypermethylation and Chemosensitivity of Gastric Cancer

Predictive value of the serum RASSF10 promoter methylation status in gastric cancer.

Promoter Methylation of P16 Associated with Helicobacter Pylori Infection in Precancerous Gastric Lesions: A Population‐based Study

Correlation Between Methylation of the P16 Promoter and Cervical Cancer Incidence.

Methylation and Expression of Gene P16ink4a and RB in Gastric Carcinomas

Detection of P16 Gene Methylation by Methylation-Specific PCR and Its Clinical Significance in Lung Cancer